Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10969303 | Vaccine | 2011 | 11 Pages |
Abstract
Most data about the relative effects of different PCV schedules relate to immunological outcomes. Both 3p and 2p schedules result in high levels of seropositivity. The clinical relevance of differences in immunological outcomes between schedules is not known. There is an absence of clinical outcome data from RCTs with direct comparisons of any 2p with any 3p PCV schedule.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Pippa Scott, Anne W.S. Rutjes, Lilian Bermetz, Nadège Robert, Susana Scott, Tania Lourenço, Matthias Egger, Nicola Low,